BPG is committed to discovery and dissemination of knowledge
Home / Archive / Volume 10, Issue 16
  • This Article
Peer-Review Report of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Journal Information of This Article
Publication Name
World Journal of Clinical Cases
ISSN
2307-8960
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Case Report
©The Author(s) 2022.
World J Clin Cases. Jun 6, 2022; 10(16): 5502-5509
Published online Jun 6, 2022. doi: 10.12998/wjcc.v10.i16.5502
Figure 4
Full Size Figure Download Figure
Figure 4 Histological findings of metastatic lymph nodes. A and B: Metastatic lymph node with large cell neuroendocrine carcinoma [A, hematoxylin-eosin (HE), × 100; B, HE, × 400]; C and D: Metastatic lymph node with small cell neuroendocrine carcinoma (C, HE, × 200; D, HE, × 400); E and F: Metastatic lymph node with mixed large and small cell neuroendocrine carcinoma. The orange arrow points to large cell neuroendocrine carcinoma, and the green arrow points to small cell neuroendocrine carcinoma (E, HE, × 100; F, HE, × 200); G: Large cell neuroendocrine carcinoma components of mixed large and small cell neuroendocrine carcinoma lymph nodes (HE, × 400); H: Small cell neuroendocrine carcinoma components of mixed large and small cell neuroendocrine carcinoma lymph nodes (HE, × 400).
Write to the Help Desk
Copyright © 1993-2026 Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA. All rights reserved, including rights relating to text and data mining, AI training, and similar technologies. For open-access content, the applicable copyright and licensing terms govern.